MaxCyte, Inc. Property, Plant and Equipment, Transfers and Changes
MaxCyte, Inc. (MXCT) reported Property, Plant and Equipment, Transfers and Changes of $222.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:PropertyPlantAndEquipmentTransfersAndChanges · last filed 2026-08-13
- MaxCyte, Inc. property, plant and equipment, transfers and changes for the quarter ending 2026-06-30 was $123.00K, a 583.33% increase year-over-year.
- MaxCyte, Inc. property, plant and equipment, transfers and changes for the quarter ending 2026-03-31 was $99.00K, a 125.00% increase year-over-year.
- MaxCyte, Inc. property, plant and equipment, transfers and changes for the quarter ending 2025-12-31 was -$15.00K, a 200.00% decline year-over-year.
- MaxCyte, Inc. property, plant and equipment, transfers and changes for the quarter ending 2025-09-30 was $69.00K, a 2.99% increase year-over-year.
- MaxCyte, Inc. property, plant and equipment, transfers and changes for fiscal 2025 was $116.00K, a 36.26% decline from fiscal 2024.
- MaxCyte, Inc. property, plant and equipment, transfers and changes for fiscal 2024 was $182.00K, a 3.70% decline from fiscal 2023.
- MaxCyte, Inc. property, plant and equipment, transfers and changes for fiscal 2023 was $189.00K, a 28.68% decline from fiscal 2022.
- MaxCyte, Inc. property, plant and equipment, transfers and changes for fiscal 2022 was $265.00K, a 48.74% decline from fiscal 2021.
| Period end | Property, Plant and Equipment, Transfers and Changes 3 month | Property, Plant and Equipment, Transfers and Changes 6 month | Property, Plant and Equipment, Transfers and Changes 9 month | Property, Plant and Equipment, Transfers and Changes 9 month as first filed | Property, Plant and Equipment, Transfers and Changes 12 month | Property, Plant and Equipment, Transfers and Changes 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $222.00K 10-Q · filed 2026-08-13 | $207.00K derived: sum of 3 quarters · filed 2026-08-13 | $276.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $99.00K 10-Q · filed 2026-05-13 | $84.00K derived: sum of 2 quarters · filed 2026-05-13 | $153.00K derived: sum of 3 quarters · filed 2026-05-13 | $171.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $54.00K derived: sum of 2 quarters · filed 2026-03-25 | $72.00K derived: sum of 3 quarters · filed 2026-08-13 | $116.00K 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $87.00K derived: sum of 2 quarters · filed 2026-08-13 | $131.00K 10-Q · filed 2025-11-13 | $146.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $62.00K 10-Q · filed 2026-08-13 | $77.00K derived: sum of 3 quarters · filed 2026-08-13 | $144.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $44.00K 10-Q · filed 2026-05-13 | $59.00K derived: sum of 2 quarters · filed 2026-05-13 | $126.00K derived: sum of 3 quarters · filed 2026-05-13 | $126.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $82.00K derived: sum of 2 quarters · filed 2026-03-25 | $82.00K derived: sum of 3 quarters · filed 2026-03-25 | $182.00K 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $67.00K derived: sum of 2 quarters · filed 2025-11-13 | $167.00K 10-Q · filed 2025-11-13 | $220.00K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $100.00K 10-Q · filed 2025-08-06 | $153.00K derived: sum of 3 quarters · filed 2025-08-06 | $182.00K derived: sum of 4 quarters · filed 2025-08-06 | ||
| 2024-03-31 | $100.00K 10-Q · filed 2025-05-08 | $153.00K derived: sum of 2 quarters · filed 2025-05-08 | $182.00K derived: sum of 3 quarters · filed 2025-05-08 | $262.00K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $82.00K derived: sum of 2 quarters · filed 2025-03-11 | $162.00K derived: sum of 3 quarters · filed 2025-03-11 | $189.00K 10-K · filed 2025-03-11 | ||
| 2023-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $109.00K derived: sum of 2 quarters · filed 2024-11-06 | $136.00K 10-Q · filed 2024-11-06 | $135.60K 10-Q · filed 2023-11-08 | $227.30K derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $107.00K 10-Q · filed 2024-08-06 | $198.30K derived: sum of 3 quarters · filed 2024-08-06 | $249.90K derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $27.00K 10-Q · filed 2024-05-07 | $118.30K derived: sum of 2 quarters · filed 2024-05-07 | $169.90K derived: sum of 3 quarters · filed 2024-05-07 | $292.00K derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | $91.30K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $142.90K derived: sum of 2 quarters · filed 2024-03-12 | $265.00K derived: sum of 3 quarters · filed 2024-03-12 | $265.00K 10-K · filed 2024-03-12 | $265.30K 10-K · filed 2023-03-15 | |
| 2022-09-30 | $51.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $173.70K derived: sum of 2 quarters · filed 2023-11-08 | $173.70K 10-Q · filed 2023-11-08 | $272.50K derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $122.10K 10-Q · filed 2022-08-10 | $122.10K 10-Q · filed 2023-08-09 | $220.90K derived: sum of 3 quarters · filed 2023-05-10 | $359.90K derived: sum of 4 quarters · filed 2023-05-10 | ||
| 2022-03-31 | $49.40K 10-Q · filed 2023-05-10 | $98.80K derived: sum of 2 quarters · filed 2023-05-10 | $237.80K derived: sum of 3 quarters · filed 2023-05-10 | $566.40K derived: sum of 4 quarters · filed 2023-05-10 | ||
| 2021-12-31 | $49.40K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $188.40K derived: sum of 2 quarters · filed 2023-03-15 | $517.00K derived: sum of 3 quarters · filed 2023-03-15 | $517.00K 10-K · filed 2023-03-15 | ||
| 2021-09-30 | $139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $467.60K derived: sum of 2 quarters · filed 2022-11-09 | $467.60K 10-Q · filed 2022-11-09 | $651.20K derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $328.60K 10-Q · filed 2022-08-10 | $328.60K 10-Q · filed 2021-09-13 | $512.20K derived: sum of 3 quarters · filed 2022-08-10 | $591.00K derived: sum of 4 quarters · filed 2022-08-10 | ||
| 2021-03-31 | $139.80K 10-Q · filed 2022-05-09 | $183.60K derived: sum of 2 quarters · filed 2022-05-09 | $262.40K derived: sum of 3 quarters · filed 2022-05-09 | |||
| 2020-12-31 | $43.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $122.60K derived: sum of 2 quarters · filed 2022-03-22 | $276.60K 10-K · filed 2022-03-22 | |||
| 2020-09-30 | $78.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $232.80K 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $154.00K 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |